UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

BMC nephrology, 2018-04, Vol.19 (1), p.97-97, Article 97

2018

Volltextzugriff (PDF)

Proteinuria Induced by Parenteral Iron in Chronic Kidney Disease—A Comparative Randomized Controlled Trial

Clinical journal of the American Society of Nephrology, 2011-01, Vol.6 (1), p.114-121

2011

Volltextzugriff (PDF)

The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

BMC nephrology, 2017-04, Vol.18 (1), p.117-117, Article 117

2017

Volltextzugriff (PDF)

Sustained Improvements in Anemia and Fatigue of AUB after a Single Course of Ferumoxytol: 6-Month Follow-up [20J]

Obstetrics and gynecology (New York. 1953), 2019-05, Vol.133 (1), p.112-113S

2019

Volltextzugriff (PDF)

Ferric gluconate is highly efficacious in anemic hemodialysis Patients with high serum ferritin and low transferrin saturation : Results of the dialysis Patients' response to IV iron with elevated ferritin (DRIVE) study

Journal of the American Society of Nephrology, 2007-03, Vol.18 (3), p.975-984

2007

Volltextzugriff (PDF)

Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy

The oncologist (Dayton, Ohio), 2007-02, Vol.12 (2), p.231-242

2007

Volltextzugriff (PDF)

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review

Therapeutics and clinical risk management, 2020-01, Vol.16, p.245-259

2020

Volltextzugriff (PDF)

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial

Clinical nephrology, 2019-04, Vol.91 (4), p.237-245

2019

Volltextzugriff (PDF)

Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia

American journal of hematology, 2011-10, Vol.86 (10), p.860-862

2011

Volltextzugriff (PDF)

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron

American journal of hematology, 2012-03, Vol.87 (3), p.308-310

2012

Volltextzugriff (PDF)

Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin

Journal of the American Society of Nephrology, 2008-02, Vol.19 (2), p.372-379

2008

Volltextzugriff (PDF)

Single-Dosage Pharmacokinetics of Sodium Ferric Gluconate Complex in Iron-Deficient Pediatric Hemodialysis Patients

Clinical journal of the American Society of Nephrology, 2007-11, Vol.2 (6), p.1140-1146

2007

Volltextzugriff (PDF)

Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community‐based, randomized study

BJU international, 2007-04, Vol.99 (4), p.836-844

2007

Volltextzugriff (PDF)

Effect of Ferumoxytol on Quality of Life in Iron Deficiency Anemia From Abnormal Uterine Bleeding

Obstetrics and gynecology (New York. 1953), 2014-05, Vol.123 (Supplement 1), p.181-182S

2014

Volltextzugriff (PDF)

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open‐label, 6‐month extension study

American journal of hematology, 2016-02, Vol.91 (2), p.E3-E5

2016

Volltextzugriff (PDF)

The impact of the overactive bladder syndrome on sexual function: A preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial

American journal of obstetrics and gynecology, 2006-12, Vol.195 (6), p.1730-1735

2006

Volltextzugriff (PDF)

Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia

BMC blood disorders, 2016-07, Vol.16 (1), p.20-20, Article 20

2016

Volltextzugriff (PDF)

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Clinical drug investigation, 2012-10, Vol.32 (10), p.707-714

2012

Volltextzugriff (PDF)

S1268 Effects of Ferric Carboxymaltose vs Ferumoxytol on Hypophosphatemia in Patients With Iron-Deficiency Anemia Due to Gastrointestinal Disorders

The American journal of gastroenterology, 2020-10, Vol.115 (1), p.S636-S637

2020

Volltextzugriff (PDF)

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA

ClinicoEconomics and outcomes research, 2017-01, Vol.9, p.557-567

2017

Volltextzugriff (PDF)

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Clinical drug investigation, 2012-10, p.1

2012

Volltextzugriff (PDF)

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

Clinical and experimental gastroenterology, 2016-01, Vol.9, p.151-162

2016

Volltextzugriff (PDF)

Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role?

Seminars in dialysis, 2008-05, Vol.21 (3), p.210-211

2008

Volltextzugriff (PDF)

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

Journal of blood medicine, 2017-01, Vol.8, p.199-209

2017

Volltextzugriff (PDF)

Erratum to Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study

PharmacoEconomics, 2012-06, Vol.30 (6), p.534-535

2012

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(53)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Humans
(28)
Female
(22)
Male
(20)
Middle Aged
(17)
Urology & Nephrology
(15)
Aged
(13)
Biological And Medical Sciences
(11)
Medical Sciences
(11)
Adult
(10)
Iron
(9)
Anemia
(8)
Adolescent
(7)
Hemodialysis
(7)
Kidney Diseases
(7)
Kidney Failure, Chronic - Therapy
(7)
Renal Dialysis
(7)
Anemia, Iron-Deficiency - Drug Therapy
(6)
Drug Therapy
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

Proteinuria Induced by Parenteral Iron in Chronic Kidney Disease—A Comparative Randomized Controlled Trial

The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

Sustained Improvements in Anemia and Fatigue of AUB after a Single Course of Ferumoxytol: 6-Month Follow-up [20J]

Ferric gluconate is highly efficacious in anemic hemodialysis Patients with high serum ferritin and low transferrin saturation : Results of the dialysis Patients' response to IV iron with elevated ferritin (DRIVE) study

Intravenous Ferric Gluconate Significantly Improves Response to Epoetin Alfa Versus Oral Iron or No Iron in Anemic Patients with Cancer Receiving Chemotherapy

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial

Safety and efficacy of rapidly administered (one hour) one gram of low molecular weight iron dextran (INFeD) for the treatment of iron deficient anemia

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron

Ferric Gluconate Reduces Epoetin Requirements in Hemodialysis Patients with Elevated Ferritin

Single-Dosage Pharmacokinetics of Sodium Ferric Gluconate Complex in Iron-Deficient Pediatric Hemodialysis Patients

Oxybutynin transdermal system improves the quality of life in adults with overactive bladder: a multicentre, community‐based, randomized study

Effect of Ferumoxytol on Quality of Life in Iron Deficiency Anemia From Abnormal Uterine Bleeding

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open‐label, 6‐month extension study

The impact of the overactive bladder syndrome on sexual function: A preliminary report from the Multicenter Assessment of Transdermal Therapy in Overactive Bladder with Oxybutynin trial

Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

S1268 Effects of Ferric Carboxymaltose vs Ferumoxytol on Hypophosphatemia in Patients With Iron-Deficiency Anemia Due to Gastrointestinal Disorders

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA

Cognitive Effects of Oxybutynin Chloride Topical Gel in Older Healthy Subjects: A 1-Week, Randomized, Double-Blind, Placebo- and Active-Controlled Study

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders

Thrombosis with erythropoietic stimulating agents-does iron-deficient erythropoiesis play a role?

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer

Erratum to Impact of transdermal oxybutynin on work productivity in patients with overactive bladder: results from the MATRIX study

Suchergebnisse filtern